Fulgent Genetics, Inc. (FLGT) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 397 transactions totaling $44.3M, demonstrating a bearish sentiment with -$25.2M in net insider flow. The most recent transaction on Dec 2, 2025 involved a sale of 1,075 shares valued at $30.5K.
No significant insider buying has been recorded for FLGT in the recent period.
No significant insider selling has been recorded for FLGT in the recent period.
Based on recent SEC filings, insider sentiment for FLGT is bearish with an Insider Alignment Score of 22/100 and a net flow of -$25.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Fulgent Genetics, Inc. (FLGT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading FLGT stock, having executed 397 transactions in the past 90 days. The most active insider is Ming Hsieh (Executive), who has made 47 transactions totaling $41.7M.
Get notified when executives and directors at FLGT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Gao Hanlin | Executive | Sale | 1,075 | $28.33 | $30.5K | |
| Dec 2, 2025 | Xie Jian | Executive | Sale | 1,140 | $28.33 | $32.3K | |
| Dec 1, 2025 | Kim Paul | Executive | Payment | 1,131 | $28.52 | $32.3K | |
| Nov 28, 2025 | Gao Hanlin | Executive | Sale | 943 | $29.57 | $27.9K | |
| Nov 28, 2025 | Xie Jian | Executive | Sale | 1,198 | $29.57 | $35.4K | |
| Nov 26, 2025 | Hsieh Ming | Executive | Payment | 2,944 | $30.15 | $88.8K | |
| Nov 26, 2025 | Kim Paul | Executive | Payment | 1,166 | $30.15 | $35.2K | |
| Nov 24, 2025 | Gao Hanlin | Executive | Sale | 535 | $30.47 | $16.3K | |
| Nov 24, 2025 | Xie Jian | Executive | Sale | 681 | $30.47 | $20.8K | |
| Nov 23, 2025 | Kim Paul | Executive | Payment | 671 | $30.00 | $20.1K | |
| Nov 23, 2025 | Hsieh Ming | Executive | Payment | 2,116 | $30.00 | $63.5K | |
| Nov 19, 2025 | Xie Jian | Executive | Sale | 10,000 | $29.10 | $291.0K | |
| Nov 19, 2025 | Xie Jian | Executive | Gift | 10,000 | $N/A | $0 | |
| Oct 26, 2025 | Xie Jian | Executive | Payment | 4,353 | $23.74 | $103.3K | |
| Oct 26, 2025 | Kim Paul | Executive | Payment | 2,743 | $23.74 | $65.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 143 | $34.8M | 39.8% |
Award(A) | 68 | $30.7M | 35.2% |
Payment(F) | 135 | $12.2M | 14.0% |
Purchase(P) | 19 | $9.6M | 10.9% |
Exercise(M) | 17 | $110.4K | 0.1% |
Gift(G) | 5 | $0 | 0.0% |
Other(J) | 6 | $0 | 0.0% |
Disposition(D) | 4 | $0 | 0.0% |
Insider selling pressure at Fulgent Genetics, Inc. has increased, with 14 insiders executing 397 transactions across all time. Total sales of $34.8M significantly outpace purchases of $9.6M, resulting in a net outflow of $25.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.